AcuraStem

Private

Pasadena, CaliforniaHealthcare & Life Scienceshttps://acurastem.com/

Last Round

Early Stage

Jun 22, 2026

Total Funding Raised

$26.73M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

AcuraStem is a biotechnology company that develops therapeutics for neurodegenerative diseases using its proprietary iNeuroRx® disease-modeling platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

drug discoverybiotechnologyprecision medicineneurodegenerative diseasestem cell researchphenotypic screeningAI drug discoveryin silico drug discoveryamyotrophic lateral sclerosisALSfrontotemporal dementiaFTDdisease modelingtherapeutic target identificationbiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AcuraStem Comps

Public and private peers based on sector, stage, and business model.

AcuraStem comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AcuraStem Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Stage VC	Jun 22, 2026
Grant	Apr 28, 2026
Grant	Mar 10, 2026
Grant	Sep 3, 2024
Grant	Jan 30, 2024
Grant	Dec 15, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Sam Alworth

Chief Executive Officer

Executive Team

AcuraStem Investors

Notable investors and investment history

AcuraStem investors
Investor	Rounds
United States Department of Defense	Grant
NIH RADx	Grant
Viva BioInnovator	Grant
Target ALS	Grant
California Institute for Regenerative Medicine	Grant
National Institute on Aging	Grant
National Institute of Neurological Disorders and Stroke	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 22, 2026
Raised an Early Stage VC round.
Apr 28, 2026
$8M grant from California Institute for Regenerative Medicine.

View all signals

AcuraStem Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AcuraStem Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AcuraStem's valuation, stock price, and market status.

Firmographic Details

HeadquartersPasadena, California

Employee Range30

Year Founded2016

Last FundingJun 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.